» Articles » PMID: 11264190

Expression of Tumor-suppressor Genes Interferon Regulatory Factor 1 and Death-associated Protein Kinase in Primitive Acute Myelogenous Leukemia Cells

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2001 Mar 27
PMID 11264190
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Previous studies indicate that human acute myelogenous leukemia (AML) arises from a rare population of leukemic stem cells. Cells of this nature can initiate and maintain leukemic cell growth in both long-term cultures and nonobese diabetic/severe combined immune-deficient mice. To characterize the biology of primitive AML cells, gene expression screens were performed with 7 primary AML and 3 normal specimens. For each sample, stem cell populations (CD34(+)/CD38(-)) were isolated and used to synthesize radiolabeled complementary DNA (cDNA). AML vs normal probes were then hybridized to cDNA arrays containing genes related to cancer and apoptosis. Of approximately 1400 genes analyzed, 2 tumor-suppressor genes were identified that were overexpressed in all 7 of the AML CD34(+)/CD38(-) cell populations: death-associated protein kinase and interferon regulatory factor 1. Expression of each gene was confirmed by reverse-transcription polymerase chain reaction and immunoblot analysis. It is proposed that tumor-suppressor proteins play a role in the biology of primitive AML cells. (Blood. 2001;97:2177-2179)

Citing Articles

IRF1 is a core transcriptional regulatory circuitry member promoting AML progression by regulating lipid metabolism.

Zhang F, Li Z, Fang F, Hu Y, He Z, Tao Y Exp Hematol Oncol. 2025; 14(1):25.

PMID: 40025540 PMC: 11871635. DOI: 10.1186/s40164-025-00612-z.


IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance.

Rundberg Nilsson A, Xian H, Shalapour S, Cammenga J, Karin M Sci Adv. 2023; 9(43):eadg5391.

PMID: 37889967 PMC: 10610924. DOI: 10.1126/sciadv.adg5391.


The landscape of gene co-expression modules correlating with prognostic genetic abnormalities in AML.

Guo C, Gao Y, Ju Q, Zhang C, Gong M, Li Z J Transl Med. 2021; 19(1):228.

PMID: 34051812 PMC: 8164775. DOI: 10.1186/s12967-021-02914-2.


CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).

Jiang Y, Xu P, Yao D, Chen X, Dai H Med Sci Monit. 2017; 23:1725-1732.

PMID: 28391288 PMC: 5395139. DOI: 10.12659/msm.900305.


Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells.

Ji Q, Ding Y, Sun Y, Zhang Y, Gao H, Song H Oncotarget. 2016; 7(40):65012-65023.

PMID: 27542251 PMC: 5323134. DOI: 10.18632/oncotarget.11342.